Syschem (India) Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 531173 |
NSE Symbol : - |
P/E(TTM) : - |
ISIN Demat : INE121D01036 |
Div & Yield% : - |
EPS(TTM) : - |
Book Value(₹) : 14.16 |
Market Cap(₹Cr) : 209.44 |
Face Value(₹) : 10.00 |
Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|---|---|
Gross Sales | 54.21 | 102.15 | 88.00 | 51.51 | 43.68 | 50.29 |
Excise Duty | 6.69 | 14.62 | 13.29 | 7.77 | 6.57 | 7.19 |
Net Sales | 47.52 | 87.53 | 74.71 | 43.74 | 37.11 | 43.10 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 0.00 | 0.01 | 0.15 | 0.01 | 0.00 | 0.00 |
Total Income | 47.52 | 87.54 | 74.86 | 43.75 | 37.11 | 43.10 |
Total Expenditure | 47.45 | 86.72 | 73.09 | 42.67 | 35.27 | 40.65 |
PBIDT | 0.07 | 0.82 | 1.77 | 1.08 | 1.85 | 2.46 |
Interest | 0.03 | 0.00 | 0.01 | 0.11 | 0.03 | 0.10 |
PBDT | 0.04 | 0.82 | 1.76 | 0.98 | 1.82 | 2.35 |
Depreciation | 0.68 | 0.68 | 0.67 | 0.74 | 0.70 | 0.68 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 1.35 | 0.00 | 0.00 | 0.00 |
Reported Profit After Tax | -0.64 | 0.14 | -0.26 | 0.23 | 1.12 | 1.68 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | -0.64 | 0.14 | -0.26 | 0.23 | 1.12 | 1.68 |
EPS (Unit Curr.) | -0.16 | 0.03 | -0.07 | 0.06 | 0.35 | 0.53 |
EPS (Adj) (Unit Curr.) | -0.16 | 0.03 | -0.07 | 0.06 | 0.35 | 0.49 |
Calculated EPS (Unit Curr.) | -0.16 | 0.03 | -0.07 | 0.06 | 0.35 | 0.53 |
Calculated EPS (Adj) (Unit Curr.) | -0.16 | 0.03 | -0.07 | 0.06 | 0.35 | 0.49 |
Calculated EPS (Ann.) (Unit Curr.) | -0.64 | 0.14 | -0.26 | 0.23 | 1.40 | 2.10 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.64 | 0.14 | -0.26 | 0.23 | 1.40 | 1.93 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 39.86 | 39.86 | 39.86 | 39.86 | 31.89 | 31.89 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 0.15 | 0.94 | 2.37 | 2.47 | 4.99 | 5.71 |
PBDTM(%) | 0.08 | 0.94 | 2.36 | 2.24 | 4.90 | 5.45 |
PATM(%) | -1.35 | 0.16 | -0.35 | 0.53 | 3.02 | 3.90 |